Breaking News

Microsize launches drug micronisation business

The US-based company has launched a company to provide services to help with API solubility and bioavailability enhancement services

Sareum notes completion of Sierra Oncology’s acquisition by GSK

Sareum Holdings, the specialist drug development company, notes that GSK has completed its acquisition of Sierra Oncology, the licence holder for S...

Merck opens $63m CDMO facility to handle HPAPIs

The industry expert has announced that its Life Science business sector has doubled its highly potent active pharmaceutical ingredients (HPAPI) pro...

Addressing the pharmaceutical industry’s energy blind spots

Paul Walsh, General Manager at CIM, explores the major energy consumption challenges facing the UK’s pharmaceutical manufacturing and life science...

Avantor and GeminiBio embark on partnership for bioproduction workflow solutions

The two US-based companies have entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biophar...

PLG acquires Pharma IT to expand pharma digitisation services

The global provider of specialised services for the pharmaceutical, medtech and biotech industries has made the acquisition in Denmark to add to se...

The legacy of COVID-19 on the pharmaceutical industry

Although the COVID-19 pandemic has by no means ended, many countries are now on the path to transitioning the virus to a state of endemicity. Yet,...

Bringing biotech to the Baltics: the rise of Lithuania

Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich poo...

Invetech announces upcoming launch of ready-to-run cell therapy systems

The biopharmaceutical industry partner has developed ready-to-run turnkey systems to produce advanced cell therapy solutions at scale and will soon...

NorthX Biologics expands cell therapy partnership with Alder Therapeutics

Sweden-based NorthX Biologics is expanding into cell therapy manufacturing at its existing GMP facility as well as in premises at the Karolinska Un...

Watered down profits

An innovative new approach to washdown and wastewater treatment creates an opportunity for pharmaceutical manufacturers, reports Mark Hardiman, CEO...

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

Optibrium receives further investment from Kester Capital

Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technol...

Remediating pharmaceutical quality systems

Much of our work involves helping companies remediate flawed quality systems. Find out the factors that can make your remediation project a success

Medix Biochemica broadens its capabilities in diagnostic base matrices with acquisition

The acquisition is another important step in the execution of Medix Biochemica’s strategy to be the first-choice raw material partner to the IVD in...

What does a pharmaceutical integrated services programme entail?

Here Kevin Duffield, Head of Client Services North America/United Kingdom discusses key attributes to look for in an integrated services provider